Research Article
Effects of Cyclosporine on Reperfusion Injury in Patients: A Meta-Analysis of Randomized Controlled Trials
Table 1
Characteristics of the study population.
| Reference | Year | Cyclosporine method | Cyclosporine dosage | Participants | Number of subjects | Age | Study design |
|
Chiari et al. [21] | 2014 | Intravenous bolus | 2.5 mg/kg | Patients accepting elective aortic valve surgery | 30 | 67 ± 11 | Prospective, monocentric, randomized, controlled, single-blind | Ghaffari et al. [13] | 2013 | Intravenous bolus | 2.5 mg/kg | Patients with acute anterior STEMI receiving TLT | 50 | 64.0 ± 11.2 | Randomized, placebo-controlled, double-blinded | Hausenloy et al. [22] | 2014 | Intravenous bolus | 2.5 mg/kg | Patients undergoing elective CABG surgery [1] | 40 | 65.8 ± 10.7 | Randomized, placebo-controlled, double-blinded | Mewton et al. [20] | 2010 | Intravenous bolus | 2.5 mg/kg | Patients with AMI accepting PCI | 15 | 60 ± 10 | Prospective, multicenter, randomized, controlled, single-blind | Piot et al. [12] | 2008 | Intravenous bolus | 2.5 mg/kg | Patients with [2] AMI accepting PCI | 30 | 58 ± 2 | Prospective, multicenter, randomized, controlled, single-blind |
|
|
STEMI: ST-elevation myocardial infarction; CABG: coronary artery bypass graft; AMI: acute myocardial infarction; PCI: percutaneous coronary intervention; TLT: thrombolytic treatment.
|